WASHINGTON - Michael Bilirakis (R-Fla.), chair of the House Commerce Committee's subcommittee on health and the environment, last week announced that he would form a bipartisan group of subcommittee members to draft FDA user fee and reform legislation.

Bilirakis emphasized the importance of reauthorizing the Prescription Drug User Fee Act (PDUFA) as well as his intention to avoid the partisan conflicts that colored last year's debates on FDA reform. "The measure of success is meaningful legislation signed by the president," he said at a hearing last week.